Zynerba Pharmaceuticals, Inc.
Save
49.02M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Pharmaceuticals
Industry

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery.

Similar securities

Based on sector and market capitalization

Report issue